Its Here! INOL (Inolife Technologies Inc) is our New Epic 2010 Finale Pick!

Epic Stock Picks Newsletter

If you are having trouble viewing this message, please go to http://community.icontact.com/p/epicstockpicks/newsletters/emot/posts/its-here-inol-inolife-technologies-inc-is-our-new-epic-2010-finale-pick Recent Winners: STHG: +1100% SCNG: +660% GFGU: +837% MILV: +1900% EFGU:

+288% IMGG: +100% [1][2][3][4][5] THE NEW EPIC 2010 FINALE PICK IS…

INOL (INOLIFE TECHNOLOGIES INC.)! Please begin your research here: [6]http://www.inolifetech.com/

Ladies and gentlemen, please lift your champagne glasses for our NEW EPIC 2010 FINALE SPECTACULAR….

INOL (INOLIFE TECHNOLOGIES INC.)! INOL closed yesterday at .0039 and trades on the OTC:BB.

After all the anticipation and on the heels of our MASSIVE 837% Gaining Christmas Present, GFGU, we have found what looks to be an excellent bottomed Sub-Penny! Only 4 months ago, INOL traded as high as .11 for a nearly 4,000% GAIN IN ONE DAY! Can INOL repeat the past and give us a New Years we`ll never forget Remember, this sub-penny is a technical *momentum alert* and can be very volatile and move fast so remember your Trading Rules. See our [7]Trading School for more tips.

CHART ANALYSIS After September`s big run, INOL looks to have finally settled down here, finding a bottom, and consolidating with signs of a new uptrend. Key resistance points will be at the 50 Day Moving Average of .0093 and the 200 DMA at .108 – well over a 100% Gain from the current price! A breach of this level could potentially set off a bullish rally. Our MACD indicator is slowly trending upwards towards the 0.0 level which confirms bullish divergence. Our stochastics indicator is looking excellent as well, trending upwards on growing buying momentum.

ABOUT INOL:

InoLife is poised to become one of the premier U.S. marketers of state-of-the-art DNA-based test products. Positioned for growth and success in a burgeoning market, InoLife Technologies, www.inolifetech.com, is primarily focused on products, services and solutions that will enable state-of-the-art healthcare for today and the future for a diverse base of customers and end users.

The Company`s mission is to identify, develop, integrate and bring to market innovative healthcare-based products and services that provide timely and practical solutions. The primary products and services that InoLife is currently addressing focuses upon those specific products and services that provide key solutions through the innovative use of specific DNA testing and Genetic analysis systems.

The principal customers of InoLife`s products and services are healthcare providers, physicians, practitioners, hospitals and outpatient facilities.

InoLife will be marketing and distributing its products through traditional distribution channels. Additionally InoLife has developed certain products that can be sold directly to consumers and has created specific programs to reach those customers including e-commerce, direct sales, healthcare providers, pharmacies, distributors, retail sellers and specialty retailers.

By leveraging their strategic partnership with InoHealth Products, Inc., INOL plans to provide the best DNA analysis products on the market.

Recently, on Dec. 9th, 2010, [8]InoLife Technologies, Inc. Retained John O`Maley and Associates to Launch Aggressive Retail Sales & Marketing Program for Company`s DNA-Based Consumer Products INOL plans to take bold steps in introducing it`s DNA-based products into the consumer market and it looks like they wont settle for anything but the best…

John O`Maley and Associates (JOA) provide over 30 years of experience in successfully launching over 40 consumer products into nearly every trade channel of the market. This company has a long-standing and trusted reputation in the retail industry in providing world-class sales presentations on products that result in significant sales and brand awareness.

John O`Maley, President of JOA, contributes his success from his training in sales and marketing, advertising and business development at Proctor & Gamble.

That experience has proven to be instrumental in generating outstanding results for his clients. JOA also uses a proven national broker network that consists of over 30 key senior account sales executives who were trained in fortune 500 companies. This ensures continuity and excellent national coverage. For more information on JOA visit www.omaley.com However, it was this press release on 9/1/2010 that really gave INOL international attention resulting in September`s legendary rally..

[9] InoLife Technologies, Inc. to Market a Plavix Metabolizing Test to the Medical Industry DNA Test Enables Physicians to Predict Medication Response in Patients for Effective Treatment InoLife Technologies, Inc. (OTC.BB:INOL – News), a service based healthcare products development, integration and marketing Company, announced today it will provide and market a proprietary metabolizing test to physicians and practitioners to identify how a patient`s genetic makeup may affect the body`s response to Plavix (colpidogrel). The test will only be made available to physicians.

The Food and Drug Administration recently announced that Plavix must now carry a so-called “black box” warning label after a landmark study revealed that patients who were “non-responders” as a result of a genetic variation were “3.58 times more likely to have a fatal stroke or myocardial infarction.” Plavix, an $8-billion-a-year drug and considered to be the second best selling drug in the world, reduces the risk of heart attack, stroke, and cardiovascular death in patients with cardiovascular disease by making platelets less likely to form blood clots. Plavix does not have its anti-platelet effects until it is metabolized into its active form by the liver enzyme, CYP2C19.

“We determined that there are three critical problems that can lead to a level of non-response to Plavix,” said Dr. Frederic J. Vagnini, M.D., FACS, a board certified cardiovascular surgeon who, after more than 20 years of performing heart surgery, has turned his clinical practice to the prevention of heart and related diseases. “First, in anyone an abnormality may be present within a gene abbreviated as CYP2C19 (and other variants) which significantly increases the risk of stroke or death due to clotting failure. Second, there are different variants or mutations between ethnic groups; some studies have indicated that one in three Caucasians and 40% of Asian of African-American populations have this abnormality.

“Among clinicians there have been discussions centering on differing dosing approaches. Perhaps the most important result of InoLife`s DNA test is that each patient will be able to have an individually tailored course of treatment since some require longer periods on it,” Vagnini stated.

InoLife Technologies feels that this is an important test for those who take Plavix or who may need to take Plavix in the future. The Company is very pleased that by addressing the black box warning, those who can be helped by this medication will be.

InoLife`s Plavix Metabolizing Test is only available to physicians and medical professionals. It is not available for home use.

INOL followed 8 days later, on Sept. 8th, announcing that their recently presented [10]Cytochrome P450 2C1 test to determine a person`s ability to metabolize Plavix is immediately available to the medical industry which includes physicians, hospitals, medical clinics, and pharmacies.

Physicians are currently placing orders on a daily basis and are incorporating the Cytochrome P450 2C1 Plavix Metabolizing test into their patients health programs.

InoLife`s Cytochrome P450 2C1 test is currently being used to identify how a patient`s genetics may affect the body`s response to Plavix (Clopidogrel). The test is available through the medical community only including physicians, hospitals, and medical clinics. This test is not available for sale to the general public.

As you can see, INOL has all the characteristics of a future player in it`s industry as well as on the market.

Today, INOL will show you why we are the #1 Financial Newsletter on the Internet Today! WE HOPE EVERYONE HAS A GREAT NEW YEARS AND HOPE THAT INOL GIVES YOU SOMETHING TO CELEBRATE GOING INTO 2011! Remember, we are now tweeting on Twitter Follow us at [11]http://www.twitter.com/EpicStockPicks Join the discussion on Facebook at [12]http://www.facebook.com/group.phpgid2592553419842&ref=ts Good Trading,[13] www.epicstockpicks.com Disclaimer: http://www.epicstockpicks.com/disclaimer This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: Epicstockpicks.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Full disclaimer can be read at http://www.epicstockpicks.com/disclaimer Release of Liability: Through use of this website viewing or using you agree to hold Epicstockpicks.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. Epicstockpicks.com has NOT been compensated for this report on INOL and GFGU. A third party may have shares and may liquidate it, which may negatively affect the stock price. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Epicstockpicks.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and Epicstockpicks.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies.

None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead Epicstockpicks.com strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. Epicstockpicks.com is compliant with the Can Spam Act of 2003. Epicstockpicks.com does not offer such advice or analysis, and Epicstockpicks.com further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor`s investment may be lost or impaired due to the speculative nature of the companies profiled.

The Private Securities Litigation Reform Act of 1995 provides investors a `safe harbor` in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be “forward looking statements”. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks an uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as “projects”, “foresee”, “expects”, “will”, “anticipates”, “estimates”, “believes”, “understands”, or that by statements indicating certain actions “may”, “could”, or “might” occur.

Understand there is no guarantee past performance will be indicative of future results.

In preparing this publication, Epicstockpicks.com has relied upon information supplied by its customers, and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however,Epicstockpicks.com and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. Epicstockpicks.com is not responsible for any claims made by the companies advertised herein, nor is Epicstockpicks.com responsible for any other promotional firm, its program or its structure.

References 1. http://www.epicstockpicks.com/

2. http://www.facebook.com/epicstockpicks 3. http://www.twitter.com/EpicStockPicks 4. http://www.epicstockpicks.com/disclaimer 5. http://www.epicstockpicks.com/contact 6. http://www.inolifetech.com/

7. http://www.epicstockpicks.com/trading-school 8. http://finance.yahoo.com/news/InoLife-Technologies-Inc-iw-929714639.htmlx=0&.v=1 9. http://finance.yahoo.com/news/InoLife-Technologies-Inc-to-iw-1155529253.htmlx=0&.v=1 10. http://finance.yahoo.com/news/InoLife-Technologies-Inc-iw-1502386553.htmlx=0&.v=1 11. http://www.twitter.com/EpicStockPicks 12. http://www.facebook.com/group.phpgid2592553419842&ref=ts 13. http://www.epicstockpicks.com/

This message was sent by: Epic Stock Picks, 215 E 24th St, New York, NY 10010

Related posts:

1. Are YOU Ready? Our Epic 2010 Finale Pick is coming TODAY @ 10 AM EST!
2. Here is Your 1st Hint for Tomorrow’s EPIC 2010 Finale PICK @ 10 AM EST!
3. GFGU is the Christmas Gift that Keeps on Giving- +650% GAINS! + CPOW now +91%!
4. GFGU is the Christmas Gift that Keeps on Giving- +650% GAINS! + CPOW now +91%!
5. GFGU (Getfugu Inc) is our New EPIC Sub-Penny PICK!